REBORN! Come and experience the unique blend of medical expertise and evidence-based strategies as we focus on creating a healthier version of YOU.
Achieving and maintaining a healthy weight can often feel like an uphill battle, but personalized, medically supervised weight loss programs offer an effective and supportive solution. These programs are tailored specifically to each individual's unique health needs and weight loss goals, ensuring a safe and sustainable approach to shedding pounds.
By working closely with MacroFusion, participants benefit from a comprehensive evaluation that includes medical history, current health status, lifestyle habits, and any underlying conditions that may affect weight loss. This thorough assessment allows for the creation of a customized plan that addresses not just diet and exercise, but also behavioral and psychological factors.
With the support and expertise of our dedicated healthcare team, individuals are empowered to achieve their weight loss goals and maintain a healthier lifestyle for years to come.
This is a 3-month program inclusive of the following:
Dosing Protocol:
Week 1 to 4: 0.25mg per week
Week 5 to 8: 0.5mg per week
Week 9 to 12: 1mg per week
Regular Price: 570.00 for 3 months ( 190.00/month)
This is a 3-month program inclusive of the following:
Dosing Protocol
Week 1 to 4: 2.5mg/week
Week 5 to 8: 5mg/week
Week 9 to 12: 7.5mg/week
Regular Price: 1,110.00 (370/month)
This is ideal for clients just starting their weight-loss journey. Covers up to 1mg of Semaglutide weekly.
This comes with the following:
This weight loss plan is ideal for clients who has been on Semaglutide prior and plans or need to be on Semaglutide of up to 2 mg a week.
This comes with the following:
Burning with passion, this plan is ideal for those clients just starting on and who desires to be on Tirzepatide of up to 7.5mg a week. This comes with the following:
This comes with the following:
Like diamonds that reflect light in an unparalleled way, especially when placed under directional spotlights, this plan is ideal for clients who plans or needs to be on Tirzepatide of up to a maximum dose of 12.5mg a week for ultimate weight loss benefit.
This comes with the following:
This comes with the following:
This comes with the following:
This comes with the following:
This comes with the following:
This comes with the following:
Large Vial lasts approximately 12 weeks at 1mg/week, 8 weeks at 1.5mg/week, and 6 weeks at 2mg/week maintenance dose
This comes with the following:
This comes with the following:
This will last for approximately 12 weeks following the protocol dosing, 15 weeks at 0.5mg/week, and 7 weeks at 1mg/week maintenance dose.
This comes with the following:
This comes with the following:
Semaglutide is a medication primarily known for its effectiveness in treating type 2 diabetes. However, its impressive ability to aid in weight loss that has garnered widespread attention.
Compounding pharmacies provide a generic version of Semaglutide oftentimes in combination with Vitamin B-12. It is most commonly given as a subcutaneous injection in the lower belly once weekly.
Its versatility and effectiveness make Semaglutide a top choice for healthcare professionals and patients alike in the quest for weight loss and better health.
The secret to Semaglutide’s success lies in its clever mimicry of the hormone glucagon-like peptide-1 (GLP-1), which plays a pivotal role in appetite regulation.
By emulating the hormone incretin, Semaglutide tricks the body into feeling fuller for longer periods, thus reducing the urge to eat. This process is facilitated by slowing down gastric emptying, meaning food stays in your stomach for a longer duration.
This ingenious mechanism not only helps in controlling calorie intake but also assists in making healthier food choices, as you’re less likely to reach for quick, high-calorie snacks when you feel satiated.
The benefits of Semaglutide extend far beyond just appetite suppression. Clinical studies have shown that individuals using Semaglutide experience significant and sustained weight loss, making it a powerful tool in the battle against obesity.
Moreover, for those with type 2 diabetes, it offers the added advantage of improving blood sugar control, thereby tackling two major health issues simultaneously.
Users of Semaglutide have reported feeling more in control of their eating habits and a lowered weight set point, leading to a more positive relationship with food and overall well-being.
Semaglutide stands out as a beacon of hope for many striving to achieve their weight loss goals. It’s not just about shedding pounds; it’s about embracing a healthier, more balanced lifestyle.
As with any medication, it’s crucial to consult with healthcare professionals to determine if Semaglutide is the right fit for you.
Tirzepatide is an experimental drug that was Food and Drug Administration (FDA)-approved in 2020 to treat Type 2 diabetes (Mounjaro), and approved in 2023 to weight-loss (Zepbound).
Tirzepatide belongs to a new class of drugs.
It mimics the effects of a hormone molecule called GLP-1 (glucagon-like peptide-1) receptor agonists, such as semaglutide. Now, add the action of GIP (glucose-dependent insulinotropic polypeptide) receptor agonism to the mix. You are getting more bang for your buck with this medication.
Tirzepatide is the forerunner of a new approach to both controlling diabetes and losing weight.
Tirzepatide blocks both GLP-1 and GIP receptors, thus acting like two drugs by way of one molecule.
It not only reduces appetite and prompts the pancreas to pump out more insulin when blood sugars are elevated – just like the GLP-1 drugs – but it also stimulates the pancreas to produce additional insulin and break down stored fat.
Together, these actions cause even bigger weight loss and better control of blood sugars than medications acting only on GLP-1.
Tirzepatide acts on two fronts to lower appetite, cut calorie intake and burn fat into a leaner body mass.
Clinical trials have shown Tirzepatide to be highly effective in reducing body weight and improving glycemic control in individuals with type 2 diabetes.
The percentage of weight loss with tirzepatide substantially exceeded that achieved with other diabetes medicines, and this could be a real game-changer for people suffering from obesity and associated conditions.
Tirzepatide also improved other hallmarks and risk factors for cardiovascular disease, such as arterial blood pressure and lipid levels.
If clinical trials hold true in the real world, this could be a major advance in metabolic health.
While both Tirzepatide and Semaglutide are GLP-1 receptor agonists used in the treatment of type 2 diabetes and weight management, There are important differences between the two drugs.
Tirzepatide is not only a GLP-1 receptor agonist, (like semaglutide), but also a gastrointestinal hormone-incretin that acts on GIP receptors. This dual-action of Tirzepatide versus the single-action of Semaglutide could be hypothesised to explain Tirzepatide’s modest superiority in mediating weight loss and glycaemic control, as has become evident in direct comparative studies.
On the whole, Tirzepatide has emerged as a potent therapeutic for patients whose treatment goals have not been met using currently available drugs.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.